MGUS/MM Awareness and Genetic Insights Campaign (MAGIC)

Overview

About this study

This proposal will determine the prevalence of MGUS among people of East African descent to improve the role of ancestral genetic diversity in myeloma research, allow an opportunity for early intervention, and reduce the disparity in diagnosing and monitoring precursor conditions for an incurable cancer which disproportionately affects those of African descent.  

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adults ≥ 40 years without a diagnosis of multiple myeloma
  • Self-reported east African ancestry (including individuals of mixed east African descent)
  • Willing and able to review, understand, and provide consent before starting any study-specific procedures
  • Ability to complete questionnaire(s) by themselves or with assistance

Exclusion Criteria:

  • Known diagnosis of multiple myeloma
  • Pregnant women

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 10/30/2024. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Joselle Cook, M.B.B.S.

Open for enrollment

Contact information:

Sarah Aug

(507) 538-1301

Aug.Sarah@mayo.edu

More information

Publications

Publications are currently not available